Related Experiment Video
Updated: Jul 10, 2026
08:34
Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
Natriuretic peptides in cardiovascular diseases
Mariusz Piechota1, Maciej Banach, Anna Jacoń
1Department of Anaesthesiology and Intensive Care Unit, Boleslaw Szarecki University Hospital No. 5 in Łódź, Medical University in Łódź, Łódź, Poland.
Cellular & Molecular Biology Letters
|October 30, 2007
Summary
Natriuretic peptides and endothelins interact in cardiovascular health. Disruptions in their balance are linked to conditions like heart failure and coronary artery disease.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
Background:
- The natriuretic peptide family includes ANP, BNP, CNP, DNP, and urodilatin.
- Natriuretic peptides and endothelins exhibit closely linked activities.
- These peptides are synthesized from polypeptide precursors.
Purpose of the Study:
- To explore the relationship between natriuretic peptides and endothelins.
- To investigate the role of these peptide systems in cardiovascular diseases.
Main Methods:
- Analysis of natriuretic peptide and endothelin interactions.
- Review of observed changes in peptide release in disease states.
Main Results:
- Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) inhibit endothelin-1 (ET-1) production.
- Endothelin-1 (ET-1) stimulates natriuretic peptide synthesis.
- Altered natriuretic peptide and endothelin release are documented in cardiovascular diseases.
Conclusions:
- The interplay between natriuretic peptides and endothelins is crucial.
- Dysregulation of these systems is implicated in chronic heart failure, left ventricular dysfunction, and coronary artery disease.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...